Sign In
Buy GLOW
$34.46
+0.0167 (+0.0485%)
At Close: Jun 22, 2026
Building on the success of GLOW1 and with all patients on a 6-month dosing interval, Zenkuda (tarcocimab tedromer) demonstrated superiority to sham with 62.5% of Zenkuda-treated patients achieving a �
Glow Lifetech Grants Stock Options
03:37pm, Friday, 13'th Jun 2025
Toronto, Ontario--(Newsfile Corp. - June 13, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has granted 3,050,000 stock o
Toronto, Ontario--(Newsfile Corp. - June 2, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the first quar
Glow Lifetech Reports 2024 Financials, Delivering Record Q4 Results with 46% Quarterly Revenue Growth and Strengthened Balance Sheet
07:30am, Thursday, 01'st May 2025
Toronto, Ontario--(Newsfile Corp. - May 1, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the fourth quar
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
04:39pm, Monday, 10'th Mar 2025
Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary endpoint and all key secondary endpoints with high s
Glow Lifetech Provides Commercial Update; Continued Growth Momentum with New Product Launch & National Expansion
08:04am, Wednesday, 12'th Feb 2025
Toronto, Ontario--(Newsfile Corp. - February 12, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update highlighting i
Glow LifeTech Announces Appointment of David Côté to Board of Directors
10:43am, Monday, 27'th Jan 2025
Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the appointment of David Côté as a
Glow Lifetech Grants Stock Options
11:20am, Friday, 27'th Dec 2024
Toronto, Ontario--(Newsfile Corp. - December 27, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has granted 3,650,000 sto
Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement
06:49pm, Friday, 20'th Dec 2024
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") announces that, further to its news release dated Decemb
Glow Lifetech Announces Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement
05:04pm, Thursday, 12'th Dec 2024
Toronto, Ontario--(Newsfile Corp. - December 12, 2024) - Glow Lifetech Corp. (CSE: GLOW) ("Glow" or the "Company") announces it plans to issue 10,000,000 Shares at a deemed price of $0.20 per Share to
Glow Lifetech Reports 49% Q/Q Revenue Growth, 73% Gross Margins, and Strengthened Balance Sheet in Q3 2024
09:17am, Monday, 02'nd Dec 2024
Toronto, Ontario--(Newsfile Corp. - December 2, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the third
Glow Lifetech Announces Non-Brokered Private Placement Offering of Units and Debt Settlement
08:43am, Tuesday, 05'th Nov 2024
Toronto, Ontario--(Newsfile Corp. - November 5, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it intends to complete a non-
Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update marking a signi
Glow Announces Non-Brokered Private Placement
08:00am, Wednesday, 14'th Aug 2024
Toronto, Ontario--(Newsfile Corp. - August 14, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) ("Glow" or the "Company") is pleased to announce a non-brokered private placement financing is
Glow Lifetech Delivers 480% Quarter-Over-Quarter Revenue Growth with Industry-Leading 70% Gross Margin
06:49pm, Tuesday, 13'th Aug 2024
Toronto, Ontario--(Newsfile Corp. - August 13, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC PINK: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a business update following strong r
